What is Scilex Holding Company's intangible purchases?

Scilex Holding Company (SCLX) reported intangible purchases of $18.7M in Q1 2026.

What does intangible purchases mean?

Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.

Scilex Holding Company SCLX Intangible Purchases

Intangible Purchases at other companies

Zevra Therapeutics, Inc.ZVRA

$0-100%

Ultragenyx PharmaceuticalRARE

$5M-66.7%

Mirum Pharmaceuticals, Inc.MIRM

$10M—

Other financials

Income statement

See full

Revenue$8.6M+72.1%

Gross profit$4.2M+15.1%

Operating income-$32.2M-15.3%

Net income-$45.7M-75.0%

EPS (diluted)-$6.28-178%

Balance sheet

See full

Cash & equivalents$3.4M-42.2%

Total debt$95.4M+130%

Total equity-$249.2M-17.8%

Total assets$293.6M+272%

Cash flow

See full

Operating cash flow-$1.1M-118%

CapEx$33.3K—

Free cash flow$920.8K-63.7%

Valuation

See full

Market cap$54.86M+88.7%

Enterprise value$146.86M+120%

P/S1.6×+1.0×

Profitability

See full

Gross margin59.7%-12.3pp

Operating margin-1,034.4%-1,313pp

Net margin-1,162.4%-1,359pp

FCF margin12.2%—

Returns & leverage

See full

Return on equity170.9%—

Debt / equity0.3×—

Current ratio0.1×0.0×

Where this comes from

Reported directly by Scilex Holding Company in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Scilex Holding Company’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's intangible purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Scilex Holding Company's intangible purchases?: Scilex Holding Company (SCLX) reported intangible purchases of $18.7M in Q1 2026.
What does intangible purchases mean?: Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.